$CATB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CATABASIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CATABASIS PHARMACEUTICALS INC. Get notifications about new insider transactions in CATABASIS PHARMACEUTICALS INC for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 02 2021 | CATB | CATABASIS PHARMACE ... | Callori Fred | Director | Option Exercise | A | 2.04 | 85,000 | 173,400 | 85,000 | |
| Jun 02 2021 | CATB | CATABASIS PHARMACE ... | Clauser Noah | Chief Financial Off ... | Option Exercise | A | 2.87 | 600,000 | 1,722,000 | 600,000 | |
| Jun 02 2021 | CATB | CATABASIS PHARMACE ... | KISHBAUCH MICHAEL D | Director | Option Exercise | A | 2.04 | 100,000 | 204,000 | 100,000 | |
| Jun 02 2021 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 2.04 | 100,000 | 204,000 | 100,000 | |
| Jun 02 2021 | CATB | CATABASIS PHARMACE ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 2.04 | 100,000 | 204,000 | 100,000 | |
| Feb 03 2021 | CATB | CATABASIS PHARMACE ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 0.00 | 1,617 | 0 | 30,920 | |
| Feb 03 2021 | CATB | CATABASIS PHARMACE ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 0.00 | 4,851 | 0 | 4,851 | |
| Feb 01 2021 | CATB | CATABASIS PHARMACE ... | Violin Jonathan | Director | Option Exercise | A | 2.43 | 15,000 | 36,450 | 15,000 | |
| Feb 01 2021 | CATB | CATABASIS PHARMACE ... | Callori Fred | Director | Option Exercise | A | 2.43 | 15,000 | 36,450 | 15,000 | |
| Feb 01 2021 | CATB | CATABASIS PHARMACE ... | Callori Fred | Director | Option Exercise | A | 2.43 | 15,000 | 36,450 | 15,000 | |
| Sep 21 2020 | CATB | CATABASIS PHARMACE ... | Clauser Noah | Chief Financial Off ... | Option Exercise | A | 6.94 | 35,000 | 242,900 | 35,000 | |
| Jun 12 2020 | CATB | CATABASIS PHARMACE ... | Cole Hugh M | Director | Option Exercise | A | 6.17 | 7,500 | 46,275 | 7,500 | |
| Jun 12 2020 | CATB | CATABASIS PHARMACE ... | Harshbarger Benjamin | Secretary and Gener ... | Option Exercise | A | 6.17 | 45,000 | 277,650 | 45,000 | |
| Jun 12 2020 | CATB | CATABASIS PHARMACE ... | KISHBAUCH MICHAEL D | Director | Option Exercise | A | 6.17 | 7,500 | 46,275 | 7,500 | |
| Jun 12 2020 | CATB | CATABASIS PHARMACE ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 6.17 | 7,500 | 46,275 | 7,500 | |
| Jun 12 2020 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 6.17 | 7,500 | 46,275 | 7,500 | |
| Jun 12 2020 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 6.17 | 7,500 | 46,275 | 7,500 | |
| Jun 12 2020 | CATB | CATABASIS PHARMACE ... | Beck Joanne T. | Director | Option Exercise | A | 6.17 | 7,500 | 46,275 | 7,500 | |
| Feb 14 2020 | CATB | CATABASIS PHARMACE ... | Donovan Joanne M. | CMO; SVP Clinical D ... | Option Exercise | A | 5.32 | 60,000 | 319,200 | 60,000 | |
| Feb 14 2020 | CATB | CATABASIS PHARMACE ... | Nichols Andrew John | Chief Scientific Of ... | Option Exercise | A | 5.32 | 60,000 | 319,200 | 60,000 | |
| Feb 14 2020 | CATB | CATABASIS PHARMACE ... | Komjathy Andrew | Chief Commercial Of ... | Option Exercise | A | 5.32 | 35,000 | 186,200 | 35,000 | |
| Feb 14 2020 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | CEO and President | Option Exercise | A | 5.32 | 150,000 | 798,000 | 150,000 | |
| Feb 14 2020 | CATB | CATABASIS PHARMACE ... | Clauser Noah | Principal Financial ... | Option Exercise | A | 5.32 | 20,000 | 106,400 | 20,000 | |
| Sep 19 2019 | CATB | CATABASIS PHARMACE ... | Komjathy Andrew | Chief Commercial Of ... | Option Exercise | A | 5.92 | 44,500 | 263,440 | 44,500 | |
| Jul 30 2019 | CATB | CATABASIS PHARMACE ... | Cole Hugh M | Director | Option Exercise | A | 6.82 | 15,000 | 102,300 | 15,000 | |
| Jun 05 2019 | CATB | CATABASIS PHARMACE ... | KISHBAUCH MICHAEL D | Director | Option Exercise | A | 6.53 | 7,500 | 48,975 | 7,500 | |
| Jun 05 2019 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 6.53 | 7,500 | 48,975 | 7,500 | |
| Jun 05 2019 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 6.53 | 7,500 | 48,975 | 7,500 | |
| Feb 15 2019 | CATB | CATABASIS PHARMACE ... | Cunnane Deirdre A. | Chief Legal Officer | Option Exercise | A | 4.39 | 40,000 | 175,600 | 40,000 | |
| Feb 15 2019 | CATB | CATABASIS PHARMACE ... | Nichols Andrew John | Chief Scientific Of ... | Option Exercise | A | 4.39 | 40,000 | 175,600 | 40,000 | |
| Feb 15 2019 | CATB | CATABASIS PHARMACE ... | Donovan Joanne M. | CMO; SVP Clinical D ... | Option Exercise | A | 4.39 | 40,000 | 175,600 | 40,000 | |
| Feb 15 2019 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | CEO and President | Option Exercise | A | 4.39 | 100,000 | 439,000 | 100,000 | |
| Feb 15 2019 | CATB | CATABASIS PHARMACE ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 4.39 | 12,200 | 53,558 | 12,200 | |
| Feb 15 2019 | CATB | CATABASIS PHARMACE ... | Beck Joanne T. | Director | Option Exercise | A | 4.39 | 15,000 | 65,850 | 15,000 | |
| Jan 04 2019 | CATB | CATABASIS PHARMACE ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 4.90 | 2,800 | 13,720 | 2,800 | |
| Sep 11 2018 | CATB | CATABASIS PHARMACE ... | Cunnane Deirdre A. | Chief Legal Officer | Option Exercise | A | 0.71 | 150,000 | 106,500 | 150,000 | |
| Sep 11 2018 | CATB | CATABASIS PHARMACE ... | Nichols Andrew John | Chief Scientific Of ... | Option Exercise | A | 0.71 | 150,000 | 106,500 | 150,000 | |
| Sep 11 2018 | CATB | CATABASIS PHARMACE ... | Donovan Joanne M. | CMO; SVP Clinical D ... | Option Exercise | A | 0.71 | 150,000 | 106,500 | 150,000 | |
| Sep 11 2018 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | CEO and President | Option Exercise | A | 0.71 | 230,000 | 163,300 | 230,000 | |
| Jun 07 2018 | CATB | CATABASIS PHARMACE ... | Ross Michael Jay | Director | Option Exercise | A | 1.48 | 14,000 | 20,720 | 14,000 | |
| Jun 07 2018 | CATB | CATABASIS PHARMACE ... | KISHBAUCH MICHAEL D | Director | Option Exercise | A | 1.48 | 14,000 | 20,720 | 14,000 | |
| Jun 07 2018 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 1.48 | 14,000 | 20,720 | 14,000 | |
| Jun 07 2018 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 1.48 | 14,000 | 20,720 | 14,000 | |
| Jun 07 2018 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Option Exercise | A | 1.48 | 14,000 | 20,720 | 14,000 | |
| Feb 09 2018 | CATB | CATABASIS PHARMACE ... | Cunnane Deirdre A. | SVP, General Counse ... | Option Exercise | A | 1.28 | 100,000 | 128,000 | 100,000 | |
| Feb 09 2018 | CATB | CATABASIS PHARMACE ... | Nichols Andrew John | Chief Scientific Of ... | Option Exercise | A | 1.28 | 100,000 | 128,000 | 100,000 | |
| Feb 09 2018 | CATB | CATABASIS PHARMACE ... | Donovan Joanne M. | CMO; SVP Clinical D ... | Option Exercise | A | 1.28 | 100,000 | 128,000 | 100,000 | |
| Feb 09 2018 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | CEO and President | Option Exercise | A | 1.28 | 230,000 | 294,400 | 230,000 | |
| Feb 09 2018 | CATB | CATABASIS PHARMACE ... | Hibben Edward K. | Chief Business Offi ... | Option Exercise | A | 1.28 | 100,000 | 128,000 | 100,000 | |
| Jul 28 2017 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 1.27 | 6,500 | 8,255 | 6,500 | |
| Jul 28 2017 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 1.27 | 6,500 | 8,255 | 6,500 | |
| Jul 28 2017 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Option Exercise | A | 1.27 | 6,500 | 8,255 | 6,500 | |
| Jul 28 2017 | CATB | CATABASIS PHARMACE ... | ROSS MICHAEL JAY | Director | Option Exercise | A | 1.27 | 6,500 | 8,255 | 6,500 | |
| Feb 10 2017 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | CEO and President | Option Exercise | A | 1.24 | 200,000 | 248,000 | 200,000 | |
| Oct 05 2016 | CATB | CATABASIS PHARMACE ... | Nichols Andrew John | Chief Scientific Of ... | Option Exercise | A | 5.79 | 13,000 | 75,270 | 13,000 | |
| Sep 12 2016 | CATB | CATABASIS PHARMACE ... | Donovan Joanne M. | CMO; SVP Clinical D ... | Option Exercise | A | 4.30 | 45,000 | 193,500 | 45,000 | |
| Sep 12 2016 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | CEO and President | Option Exercise | A | 4.30 | 45,000 | 193,500 | 45,000 | |
| Sep 12 2016 | CATB | CATABASIS PHARMACE ... | Modi Rick | Chief Business Offi ... | Option Exercise | A | 4.30 | 45,000 | 193,500 | 45,000 | |
| Sep 12 2016 | CATB | CATABASIS PHARMACE ... | Cunnane Deirdre A. | SVP, General Counse ... | Option Exercise | A | 4.30 | 45,000 | 193,500 | 45,000 | |
| Aug 05 2016 | CATB | CATABASIS PHARMACE ... | GALAKATOS NICHOLAS | Director | Option Exercise | A | 4.55 | 6,500 | 29,575 | 6,500 | |
| Aug 05 2016 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Option Exercise | A | 4.55 | 6,500 | 29,575 | 6,500 | |
| Aug 05 2016 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 4.55 | 6,500 | 29,575 | 6,500 | |
| Aug 05 2016 | CATB | CATABASIS PHARMACE ... | ROSS MICHAEL JAY | Director | Option Exercise | A | 4.55 | 6,500 | 29,575 | 6,500 | |
| Apr 07 2016 | CATB | CATABASIS PHARMACE ... | KISHBAUCH MICHAEL D | Director | Option Exercise | A | 4.80 | 13,000 | 62,400 | 13,000 | |
| Apr 07 2016 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 4.80 | 13,000 | 62,400 | 13,000 | |
| Feb 16 2016 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | President and CEO | Option Exercise | A | 4.57 | 103,000 | 470,710 | 103,000 | |
| Feb 16 2016 | CATB | CATABASIS PHARMACE ... | Sanderson Ian C. | Chief Financial Off ... | Option Exercise | A | 4.57 | 52,000 | 237,640 | 52,000 | |
| Feb 16 2016 | CATB | CATABASIS PHARMACE ... | Modi Rick | Chief Business Offi ... | Option Exercise | A | 4.57 | 42,000 | 191,940 | 42,000 | |
| Feb 16 2016 | CATB | CATABASIS PHARMACE ... | Donovan Joanne M. | Chief Medical Offic ... | Option Exercise | A | 4.57 | 66,000 | 301,620 | 66,000 | |
| Feb 16 2016 | CATB | CATABASIS PHARMACE ... | Cunnane Deirdre A. | SVP, General Counse ... | Option Exercise | A | 4.57 | 23,000 | 105,110 | 23,000 | |
| Jul 21 2015 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | President and CEO | Option Exercise | A | 14.05 | 160,000 | 2,248,000 | 160,000 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Jirousek Michael | Chief Scientific Of ... | Option Exercise | C | 0.00 | 5,261 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Jirousek Michael | Chief Scientific Of ... | Option Exercise | C | 0.00 | 856,571 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Jirousek Michael | Chief Scientific Of ... | Buy | C | 0.00 | 409 | 0 | 246,093 | 245.7 K to 246.1 K (+0.17 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Jirousek Michael | Chief Scientific Of ... | Buy | C | 0.00 | 66,658 | 0 | 245,684 | 179 K to 245.7 K (+37.23 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Option Exercise | A | 12.21 | 11,094 | 135,458 | 11,094 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Option Exercise | C | 0.00 | 1,006,712 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Option Exercise | C | 0.00 | 7,388,491 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Option Exercise | C | 0.00 | 3,910,392 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Option Exercise | C | 0.00 | 8,666,667 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | P | 12.00 | 12,422 | 149,064 | 90,764 | 78.3 K to 90.8 K (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | P | 12.00 | 91,166 | 1,093,992 | 666,145 | 575 K to 666.1 K (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | P | 12.00 | 155,188 | 1,862,256 | 1,133,943 | 978.8 K to 1.1 M (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | C | 0.00 | 78,342 | 0 | 78,342 | 0 to 78.3 K |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | C | 0.00 | 574,979 | 0 | 574,979 | 0 to 575 K |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | C | 0.00 | 304,309 | 0 | 978,755 | 674.4 K to 978.8 K (+45.12 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | C | 0.00 | 674,446 | 0 | 674,446 | 0 to 674.4 K |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | GALAKATOS NICHOLAS | Director | Option Exercise | A | 12.21 | 11,094 | 135,458 | 11,094 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | GALAKATOS NICHOLAS | Director | Option Exercise | C | 0.00 | 9,728,971 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | GALAKATOS NICHOLAS | Director | Option Exercise | C | 0.00 | 20,800,000 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | GALAKATOS NICHOLAS | Director | Buy | P | 12.00 | 376,695 | 4,520,340 | 2,752,488 | 2.4 M to 2.8 M (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | GALAKATOS NICHOLAS | Director | Buy | C | 0.00 | 757,117 | 0 | 2,375,793 | 1.6 M to 2.4 M (+46.77 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | GALAKATOS NICHOLAS | Director | Buy | C | 0.00 | 1,618,676 | 0 | 1,618,676 | 0 to 1.6 M |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Donovan Joanne M. | Chief Medical Offic ... | Option Exercise | C | 0.00 | 5,261 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Donovan Joanne M. | Chief Medical Offic ... | Buy | C | 0.00 | 409 | 0 | 409 | 0 to 409 |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,728,971 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 20,800,000 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | P | 12.00 | 376,695 | 4,520,340 | 2,752,488 | 2.4 M to 2.8 M (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 757,117 | 0 | 2,375,793 | 1.6 M to 2.4 M (+46.77 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 1,618,676 | 0 | 1,618,676 | 0 to 1.6 M |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 12.21 | 11,094 | 135,458 | 11,094 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 207,558 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 9,821,385 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 448,414 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 21,218,253 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Buy | P | 12.00 | 8,094 | 97,128 | 59,139 | 51 K to 59.1 K (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Buy | P | 12.00 | 382,996 | 4,595,952 | 2,798,528 | 2.4 M to 2.8 M (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 16,152 | 0 | 51,045 | 34.9 K to 51 K (+46.29 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 764,309 | 0 | 2,415,532 | 1.7 M to 2.4 M (+46.29 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 34,893 | 0 | 34,893 | 0 to 34.9 K |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 1,651,223 | 0 | 1,651,223 | 0 to 1.7 M |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | ROSS MICHAEL JAY | Director | Option Exercise | A | 12.21 | 11,094 | 135,458 | 11,094 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Modi Rick | Chief Business Offi ... | Option Exercise | C | 0.00 | 52,614 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Modi Rick | Chief Business Offi ... | Buy | C | 0.00 | 4,094 | 0 | 4,094 | 0 to 4.1 K |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | President and CEO | Option Exercise | C | 0.00 | 105,229 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | President and CEO | Option Exercise | C | 0.00 | 856,548 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | President and CEO | Buy | C | 0.00 | 8,189 | 0 | 253,872 | 245.7 K to 253.9 K (+3.33 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | President and CEO | Buy | C | 0.00 | 66,657 | 0 | 245,683 | 179 K to 245.7 K (+37.23 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 4,241,780 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 13,866,666 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | P | 12.00 | 223,439 | 2,681,268 | 1,632,652 | 1.4 M to 1.6 M (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 330,098 | 0 | 1,409,213 | 1.1 M to 1.4 M (+30.59 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 1,079,115 | 0 | 1,079,115 | 0 to 1.1 M |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Laufer Ron | Director | Option Exercise | A | 12.21 | 11,094 | 135,458 | 11,094 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Laufer Ron | Director | Option Exercise | C | 0.00 | 4,241,780 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Laufer Ron | Director | Option Exercise | C | 0.00 | 13,866,666 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Laufer Ron | Director | Buy | P | 12.00 | 223,439 | 2,681,268 | 1,632,652 | 1.4 M to 1.6 M (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Laufer Ron | Director | Buy | C | 0.00 | 330,098 | 0 | 1,409,213 | 1.1 M to 1.4 M (+30.59 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Laufer Ron | Director | Buy | C | 0.00 | 1,079,115 | 0 | 1,079,115 | 0 to 1.1 M |
Page: 1